Literature DB >> 21199647

Implication of the melanocortin-3 receptor in the regulation of food intake.

Boman G Irani1, Zhimin Xiang, Hossein N Yarandi, Jerry R Holder, Marcus C Moore, Rayna M Bauzo, Bettina Proneth, Amanda M Shaw, William J Millard, James B Chambers, Stephen C Benoit, Deborah J Clegg, Carrie Haskell-Luevano.   

Abstract

The melanocortin system is well recognized to be involved in the regulation of food intake, body weight, and energy homeostasis. To probe the role of the MC(3) in the regulation of food intake, JRH322-18 a mixed MC(3) partial agonist/antagonist and MC(4) agonist tetrapeptide was examined in wild type (WT) and melanocortin 4 receptor (MC(4)) knockout mice and shown to reduce food intake in both models. In the wild type mice, 2.0 nmol of JRH322-18 statistically reduced food intake 4h post icv treatment into satiated nocturnally feeding wild type mice. The same dose in the MC(4)KO mice significantly reduced cumulative food intake 24h post treatment. Conditioned taste aversion as well as activity studies supports that the decreased food intake was not due to visceral illness. Since these studies resulted in loss-of-function results, the SHU9119 and agouti-related protein (AGRP) melanocortin receptor antagonists were administered to wild type as well as the MC(3) and MC(4) knockout mice in anticipation of gain-of-function results. The SHU9119 ligand produced an increase in food intake in the wild type mice as anticipated, however no effect was observed in the MC(3) and MC(4) knockout mice as compared to the saline control. The AGRP ligand however, produced a significant increase in food intake in the wild type as well as the MC(3) and MC(4) knockout mice and it had a prolonged affect for several days. These data support the hypothesis that the MC(3) plays a subtle role in the regulation of food intake, however the mechanism by which this is occurring remains to be determined.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21199647      PMCID: PMC3095750          DOI: 10.1016/j.ejphar.2010.10.101

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  28 in total

1.  Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat.

Authors:  M A Cowley; N Pronchuk; W Fan; D M Dinulescu; W F Colmers; R D Cone
Journal:  Neuron       Date:  1999-09       Impact factor: 17.173

2.  Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression.

Authors:  J E McMinn; C W Wilkinson; P J Havel; S C Woods; M W Schwartz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-08       Impact factor: 3.619

3.  Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion.

Authors:  T E Thiele; G van Dijk; K A Yagaloff; S L Fisher; M Schwartz; P Burn; R J Seeley
Journal:  Am J Physiol       Date:  1998-01

4.  The agouti-related protein decapeptide (Yc[CRFFNAFC]Y) possesses agonist activity at the murine melanocortin-1 receptor.

Authors:  C Haskell-Luevano; E K Monck; Y P Wan; A M Schentrup
Journal:  Peptides       Date:  2000-05       Impact factor: 3.750

5.  Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues.

Authors:  D J Marsh; G I Miura; K A Yagaloff; M W Schwartz; G S Barsh; R D Palmiter
Journal:  Brain Res       Date:  1999-11-27       Impact factor: 3.252

6.  Food demand and meal size in mice with single or combined disruption of melanocortin type 3 and 4 receptors.

Authors:  Deniz Atalayer; Kimberly L Robertson; Carrie Haskell-Luevano; Amy Andreasen; Neil E Rowland
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-04-07       Impact factor: 3.619

7.  Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade.

Authors:  M M Hagan; P A Rushing; L M Pritchard; M W Schwartz; A M Strack; L H Van Der Ploeg; S C Woods; R J Seeley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-07       Impact factor: 3.619

8.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.

Authors:  W Fan; B A Boston; R A Kesterson; V J Hruby; R D Cone
Journal:  Nature       Date:  1997-01-09       Impact factor: 49.962

9.  Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study.

Authors:  H Wessells; K Fuciarelli; J Hansen; M E Hadley; V J Hruby; R Dorr; N Levine
Journal:  J Urol       Date:  1998-08       Impact factor: 7.450

10.  Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.

Authors:  D J Marsh; G Hollopeter; D Huszar; R Laufer; K A Yagaloff; S L Fisher; P Burn; R D Palmiter
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

View more
  43 in total

1.  A Macrocyclic Agouti-Related Protein/[Nle4,DPhe7]α-Melanocyte Stimulating Hormone Chimeric Scaffold Produces Subnanomolar Melanocortin Receptor Ligands.

Authors:  Mark D Ericson; Katie T Freeman; Sathya M Schnell; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2017-01-17       Impact factor: 7.446

2.  Synthesis and Pharmacology of α/β(3)-Peptides Based on the Melanocortin Agonist Ac-His-dPhe-Arg-Trp-NH2 Sequence.

Authors:  Anamika Singh; Srinivasa R Tala; Viktor Flores; Katie Freeman; Carrie Haskell-Luevano
Journal:  ACS Med Chem Lett       Date:  2015-04-08       Impact factor: 4.345

3.  Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a μM MC4R Partial Agonist.

Authors:  Katlyn A Fleming; Katie T Freeman; Mike D Powers; Radleigh G Santos; Ginamarie Debevec; Marc A Giulianotti; Richard A Houghten; Skye R Doering; Clemencia Pinilla; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2019-02-28       Impact factor: 7.446

4.  Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles.

Authors:  Mark D Ericson; Zoe M Koerperich; Katie T Freeman; Katlyn A Fleming; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2018-07-20       Impact factor: 4.418

5.  Structure-activity relationships of peptides incorporating a bioactive reverse-turn heterocycle at the melanocortin receptors: identification of a 5800-fold mouse melanocortin-3 receptor (mMC3R) selective antagonist/partial agonist versus the mouse melanocortin-4 receptor (mMC4R).

Authors:  Anamika Singh; Marvin Dirain; Rachel Witek; James R Rocca; Arthur S Edison; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2013-03-25       Impact factor: 7.446

6.  Genetic dissection of the functions of the melanocortin-3 receptor, a seven-transmembrane G-protein-coupled receptor, suggests roles for central and peripheral receptors in energy homeostasis.

Authors:  Karima Begriche; Peter R Levasseur; Jingying Zhang; Jari Rossi; Danielle Skorupa; Laura A Solt; Brandon Young; Thomas P Burris; Daniel L Marks; Randall L Mynatt; Andrew A Butler
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

7.  Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists.

Authors:  Katlyn A Fleming; Katie T Freeman; Mark D Ericson; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2018-08-16       Impact factor: 7.446

8.  An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers.

Authors:  Cody J Lensing; Katie T Freeman; Sathya M Schnell; Danielle N Adank; Robert C Speth; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2016-03-29       Impact factor: 7.446

9.  Comparative Functional Alanine Positional Scanning of the α-Melanocyte Stimulating Hormone and NDP-Melanocyte Stimulating Hormone Demonstrates Differential Structure-Activity Relationships at the Mouse Melanocortin Receptors.

Authors:  Aleksandar Todorovic; Mark D Ericson; Ryan D Palusak; Nicholas B Sorensen; Michael S Wood; Zhimin Xiang; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2016-05-17       Impact factor: 4.418

10.  Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor.

Authors:  Alfonso Carotenuto; Francesco Merlino; Minying Cai; Diego Brancaccio; Ali Munaim Yousif; Ettore Novellino; Victor J Hruby; Paolo Grieco
Journal:  J Med Chem       Date:  2015-12-16       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.